At Strand Life Sciences, we believe that the key to fighting cancer lies in early detection. Our groundbreaking multi-cancer early detection test is designed to identify traces of cancer with unparalleled precision, even in the earliest stages. By analyzing signatures of specific chemical modifications in DNA molecules (methylation),we can detect potential cancer signals with a simple blood draw.
Fragments of tumor DNA shed into the bloodstream by cancer cells
A natural process that involves adding chemical tags (methyl groups) to DNA, influencing gene activity



Advanced technologies can detect these unique methylation patterns in ctDNA.

By analyzing these abnormal patterns, early-stage cancers can be detected before symptoms appear.



Strand’s Cancer Early Detection Test is designed for adults aged 50 and older who face an increased risk of cancer. This includes individuals with a family history of cancer, those with lifestyle risk factors, or anyone seeking an extra layer of protection alongside routine screenings. It is especially valuable for people looking to detect cancer in its early stages before symptoms appear, improving the chances of successful treatment and better outcomes.
This test is not recommended for individuals who are pregnant, under the age of 21, or currently receiving active cancer treatment.






*Disclaimer: Note that the above information is not intended for any action on your part for diagnosis, cure, mitigation, treatment or prevention of disease. Any action based on this information should be taken only on the recommendation of a medical specialist.